Analysts Set Option Care Health, Inc. (NASDAQ:OPCH) PT at $36.27

Shares of Option Care Health, Inc. (NASDAQ:OPCH) have been given a consensus rating of “Moderate Buy” by the fourteen analysts that are currently covering the firm, Marketbeat.com reports. Three analysts have rated the stock with a hold rating, ten have issued a buy rating and one has assigned a strong buy rating to the company. The average 12-month price objective among analysts that have issued a report on the stock in the last year is $36.2727.

A number of equities research analysts have recently weighed in on OPCH shares. Wall Street Zen raised Option Care Health from a “hold” rating to a “buy” rating in a report on Saturday. Barrington Research reaffirmed an “outperform” rating and set a $38.00 target price on shares of Option Care Health in a research note on Friday, October 31st. Stephens upgraded Option Care Health to a “strong-buy” rating in a research report on Thursday, December 11th. Morgan Stanley initiated coverage on Option Care Health in a research note on Friday, October 17th. They issued an “overweight” rating and a $35.00 price target for the company. Finally, TD Cowen cut their price objective on shares of Option Care Health from $30.00 to $27.00 and set a “hold” rating on the stock in a research note on Monday, November 3rd.

Insider Activity at Option Care Health

In related news, Director Harry M. Jansen Kraemer, Jr. purchased 38,000 shares of the company’s stock in a transaction on Monday, November 3rd. The shares were bought at an average cost of $25.98 per share, for a total transaction of $987,240.00. Following the transaction, the director owned 413,390 shares of the company’s stock, valued at $10,739,872.20. This represents a 10.12% increase in their ownership of the stock. The purchase was disclosed in a document filed with the SEC, which is available through this link. Company insiders own 0.64% of the company’s stock.

Institutional Investors Weigh In On Option Care Health

Several hedge funds and other institutional investors have recently added to or reduced their stakes in OPCH. USA Financial Formulas acquired a new stake in Option Care Health in the second quarter worth approximately $26,000. Cornerstone Planning Group LLC lifted its holdings in shares of Option Care Health by 7,621.4% in the third quarter. Cornerstone Planning Group LLC now owns 1,081 shares of the company’s stock valued at $30,000 after buying an additional 1,067 shares during the period. Northwestern Mutual Wealth Management Co. boosted its stake in Option Care Health by 1,492.9% during the first quarter. Northwestern Mutual Wealth Management Co. now owns 892 shares of the company’s stock valued at $31,000 after buying an additional 836 shares in the last quarter. Advisory Services Network LLC bought a new position in Option Care Health during the third quarter valued at about $35,000. Finally, McIlrath & Eck LLC acquired a new position in Option Care Health during the second quarter worth about $37,000. Institutional investors own 98.05% of the company’s stock.

Option Care Health Stock Down 0.6%

OPCH stock opened at $31.78 on Friday. The stock has a market cap of $5.04 billion, a PE ratio of 25.22, a price-to-earnings-growth ratio of 1.99 and a beta of 0.80. The firm’s 50-day simple moving average is $30.72 and its 200 day simple moving average is $29.44. Option Care Health has a fifty-two week low of $23.68 and a fifty-two week high of $35.53. The company has a quick ratio of 1.05, a current ratio of 1.56 and a debt-to-equity ratio of 0.85.

About Option Care Health

Option Care Health (NASDAQ: OPCH) is a leading provider of home and alternate site infusion services in the United States. The company specializes in the administration of injectable therapies, including antibiotics, nutrition, hydration, immunoglobulin, pain management and specialty pharmaceuticals. Through its nationwide network of infusion pharmacies and nursing professionals, Option Care Health delivers customized care plans and in-home nursing visits to patients managing complex or chronic conditions outside of a hospital setting.

Option Care Health traces its current structure to the completion of its merger with BioScrip in early 2021, combining two of the industry’s most experienced home infusion businesses.